This product is an aptamer which binds to the Human EPHB2 with an affinity of 200-1000 nM.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Target Category | Protein |
| Target | EPHB2 |
| Alternative Names | EPH Receptor B2 EPHT3 HEK5 DRT ERK Developmentally-Regulated Eph-Related Tyrosine Kinase Tyrosine-Protein Kinase Receptor EPH-3 Renal Carcinoma Antigen NY-REN-47 Tyrosine-Protein Kinase TYRO5 Ephrin Type-B Receptor 2 EPH-Like Kinase 5 Tyro5 TYRO5 Hek5 EK5 Protein-Tyrosine Kinase HEK5 Elk-Related Tyrosine Kinase ELK-Related Tyrosine Kinase Eph Tyrosine Kinase 3 EPH Tyrosine Kinase 3 BDPLT22 3 EphB2 EPTH3 CAPB PCBC |
| Gene ID | 2048 |
| UniProt ID | P29323 |
| Target Overview | This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. |
| Chemical Modification | 2'-fluoro pyrimidines |
| Type | RNA |
| Species Reactivity | Human |
| Length | <50 nt |
| Affinity (Kd) | 200-1000 nM |
| Binding Conditions/Buffer | PBS, 1 mM MgCl₂, and 0.15% Tween-20, pH 7.4 |
| GC Content | 42.11% |
| Molecular Weight | 11614.50 g/mole |
| nmoles/OD260 | 2.67 |